Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
RoB 2: a revised tool for assessing risk of bias in randomised trials
28.245
Zitationen
28
Autoren
2019
Jahr
Abstract
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Ähnliche Arbeiten
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · 84.807 Zit.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 · 82.774 Zit.
The Measurement of Observer Agreement for Categorical Data
1977 · 76.832 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 62.698 Zit.
Measuring inconsistency in meta-analyses
2003 · 61.430 Zit.
Autoren
- Jonathan A C Sterne
- Jelena Savović
- Matthew J. Page
- Roy G. Elbers
- Natalie Blencowe
- Isabelle Boutron
- Christopher J Cates
- Hung‐Yuan Cheng
- Mark Corbett
- Sandra Eldridge
- Jonathan Emberson
- Miguel A. Hernán
- Sally Hopewell
- Asbjørn Hróbjartsson
- Daniela R. Junqueira
- Peter Jüni
- Jamie J Kirkham
- Toby J Lasserson
- Tianjing Li
- Alexandra McAleenan
- Barnaby C Reeves
- Sasha Shepperd
- Ian Shrier
- Lesley Stewart
- Kate Tilling
- Ian R. White
- Penny Whiting
- Julian P. T. Higgins
Institutionen
- University of Bristol(GB)
- NIHR Bristol Biomedical Research Centre(GB)
- University Hospitals Bristol NHS Foundation Trust(GB)
- Monash University(AU)
- Inserm(FR)
- Université Paris Cité(FR)
- Délégation Paris 5(FR)
- St George's, University of London(GB)
- University of York(GB)
- Queen Mary University of London(GB)
- University of Oxford(GB)
- MRC Epidemiology Unit(GB)
- Harvard–MIT Division of Health Sciences and Technology(US)
- Nuffield Orthopaedic Centre(GB)
- Odense University Hospital(DK)
- University of Southern Denmark(DK)
- University of Alberta(CA)
- St. Michael's Hospital(CA)
- University of Manchester(GB)
- Cochrane(GB)
- Johns Hopkins University(US)
- McGill University(CA)
- Jewish General Hospital(CA)
- University College London(GB)
- MRC Clinical Trials Unit at UCL(GB)